- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06844968
The Effect of a 2000-m Ergometer Test on Training Status Indicators and the Muscle Adaptation in Rowers (ETTETTSIAMAR)
February 21, 2025 updated by: Poznan University of Physical Education
Multi-Faced Optimization of Sports Training Focused on Training Status Energy and Muscle Adaptation to Effort
Intense physical exercise can lead to micro-damage to tissues and activation of inflammatory processes, the body's natural response to exercise-related metabolic stress.
Monitoring inflammation and fatigue will enable the observation of athletes in terms of post-exercise regeneration and muscle adaptation to physical effort.
The obtained results will allow for estimating the level of fatigue, minimizing the risk of injury, and will show the rate of post-exercise regeneration or its absence.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will involve 40 members of the Polish Youth Rowing Team, both sexes, aged 19-23.
The study will be held on three dates related to the specifics of the athletes' training cycle, i.e. in the preparatory period (March), the competition period (June), and the detraining period (November).
The participants will perform an intensive exercise test on a rowing ergometer (manufacturer: Concept II, USA), covering a distance of 2,000 meters in the shortest possible time.
The study will involve 40 members of the Polish Youth Rowing Team, both sexes, aged 19-23.
Each time, before starting the exercise test, a non-invasive anthropometric analysis will be performed using the TANITA MC-780MA body composition analyzer (tanita Japan), to determine the body composition: percentage of body fat, body fat mass, lean tissue mass, muscle mass, body water and body mass index (BMI).
On the three indicated dates, before and after the stress test, capillary blood (ear lobe) from the cubital vein will be collected from the participants.
Using immunoenzymatic ELISA tests, the following will be determined: EPO (erythropoietin), VEGF (vascular endothelial growth factor), CRP (C-reactive protein), glycogen, hypoxanthine (Hx).
Glucose level will be determined using an Accu-Chek Active glucometer (Roche, Germany).
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Polska
-
Gorzów Wielkopolski, Polska, Poland, 66-400
- Poznań University of Physical Education, Faculty of Physical Culture in Gorzów Wielkopolski
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- members of the Polish Youth Rowing Team - competitors officially called up to the Polish national rowing team,
- no musculoskeletal injuries that would prevent them from performing the exercise test,
- written consent of the competitor to participate in the study.
Exclusion Criteria:
- anti-inflammatory drugs, other supplements in the last 3 months before starting the study,
- failure to complete the test,
- current injury, post-traumatic condition, illness,
- lack of informed consent of the athlete.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Physical effort
The effort on the rowing ergometer, based on swimming a specified distance in the shortest possible time.
|
The examined rowers will be subjected to an effort on a rowing ergometer, consisting of covering a designated distance in the shortest possible time.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EPO (erythropoietin) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
|
Immunoenzymatic assay method using a diagnostic ELISA Kit
|
Immediately before the ergometer test, immediately after and 3 hours after the test
|
|
VEGF (vascular endothelial growth factor) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
|
Immunoenzymatic assay method using a diagnostic ELISA Kit
|
Immediately before the ergometer test, immediately after and 3 hours after the test
|
|
Hypoxanthine (Hx) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
|
Immunoenzymatic assay method using a diagnostic ELISA Kit
|
Immediately before the ergometer test, immediately after and 3 hours after the test
|
|
Glycogen level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
|
Immunoenzymatic assay method using a diagnostic ELISA Kit
|
Immediately before the ergometer test, immediately after and 3 hours after the test
|
|
Glucose level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
|
Using an Accu-Chek Active glucometer (Roche, Germany)
|
Immediately before the ergometer test, immediately after and 3 hours after the test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Anna Kasperska, PhD, Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland;
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2024
Primary Completion (Actual)
November 30, 2024
Study Completion (Actual)
November 30, 2024
Study Registration Dates
First Submitted
January 9, 2025
First Submitted That Met QC Criteria
February 21, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 21, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- Rowers 2024
- RPW/8857/2024 (Other Identifier: Ministry of Sport and Tourism)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exhaustion - Physiological
-
University of Trás-os-Montes and Alto DouroCompletedExhaustion - PhysiologicalBrazil
-
Lindenwood UniversityIncrenovo, LLCCompletedLactate Blood Increase | Exhaustion - PhysiologicalUnited States
-
University Hospital, Strasbourg, FranceRecruitingGeriatric Disorder | ExhaustionFrance
-
Uppsala UniversityNot yet recruitingBurnout | Exhaustion Disorder | Clinical Burnout
-
NYU Langone HealthCompletedExhaustion; SyndromeUnited States
-
Harvard School of Public Health (HSPH)Fogarty International Center of the National Institute of HealthRecruitingHeat Stress | Heat Exposure | Heat Effect | Hot Weather; Adverse Effect | Heat Stroke, Heat Exhaustion | Heat StrainUnited States
-
Victoria BlomAvonova Health AB; Jenny Kling, Doctoral student, licensed psychologist, The...Completed
-
Stanford UniversityCompleted
-
Uppsala UniversityPBM Sweden ABCompletedExhaustion Disorder | Clinical BurnoutSweden
-
University Hospitals Coventry and Warwickshire...Coventry UniversityRecruitingHeart Failure | Myocardial Dysfunction | Fatigue; Muscle, Heart | Exhaustion; HeartUnited Kingdom
Clinical Trials on Physical effort
-
National Institute of Neurological Disorders and...RecruitingFatigue Syndrome, ChronicUnited States
-
Assistance Publique - Hôpitaux de ParisEurofins BiomnisNot yet recruiting
-
Poznan University of Physical EducationCompletedNervous System Diseases | Inflammation | Muscle Damage | FerroptosisPoland
-
Kitani, Lenore, PTCompleted
-
Groupe Hospitalier de la Region de Mulhouse et...Completed
-
Universidade Federal do Rio de JaneiroRecruitingWeaning Failure | Mechanical Ventilation Pressure HighBrazil
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownFatigue | Dyspnea | Muscle Strength | Functional Capacity
-
Loewenstein HospitalAriel UniversityUnknownChronic Pain | Traumatic Brain Damage
-
University of PittsburghNational Institute on Deafness and Other Communication Disorders (NIDCD); University...RecruitingStroke | AphasiaUnited States
-
University of New MexicoActive, not recruiting